TY  - JOUR
AU  - Nicoletti, Paola
AU  - Devarbhavi, Harshad
AU  - Goel, Ashish
AU  - Venkatesan, Radha
AU  - Eapen, Chundamannil E
AU  - Grove, Jane I
AU  - Zafer, Samreen
AU  - Bjornsson, Einar
AU  - Lucena, M Isabel
AU  - Andrade, Raul J
AU  - Pirmohamed, Munir
AU  - Wadelius, Mia
AU  - Larrey, Dominique
AU  - Maitland-van der Zee, Anke-Hilse
AU  - Ibanez, Luisa
AU  - Watkins, Paul B
AU  - Daly, Ann K
AU  - Aithal, Guruprasad P
PY  - 2020
DO  - 10.1002/cpt.2100
UR  - http://hdl.handle.net/10668/16520
T2  - Clinical pharmacology and therapeutics
AB  - Drug-induced liver injury (DILI) is a complication of treatment with antituberculosis (TB) drugs, especially in isoniazid (INH)-containing regimens. To investigate genetic risk factors, we performed a genomewide association study (GWAS) involving...
LA  - en
KW  - Adult
KW  - Aged
KW  - Antitubercular Agents
KW  - Arylamine N-Acetyltransferase
KW  - Asian People
KW  - Chemical and Drug Induced Liver Injury
KW  - Female
KW  - Genome-Wide Association Study
KW  - Genotype
KW  - Histocompatibility Antigens Class I
KW  - Humans
KW  - Isoniazid
KW  - Male
KW  - Middle Aged
KW  - Polymorphism, Single Nucleotide
KW  - Risk Factors
KW  - White People
TI  - Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens.
TY  - research article
VL  - 109
ER  -